Pemvidutide Peptide (ALT-801): A Dual-Agonist Peptide for Fatty Liver And Fat Loss
Non-alcoholic fatty liver disease (NAFLD) and obesity are two of the fastest-growing health problems worldwide. In the U.S. alone, more than 100 million adults are estimated to have fatty liver, with many progressing toward non-alcoholic steatohepatitis...